CoChat

Stellate cells: A moving target in hepatic fibrogenesis†

Open access
Friedman, Scott L. · 2004 · Hepatology
Cited by 121

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Progress in understanding the cellular and molecular basis of hepatic fibrosis continues to accelerate, leading to an understanding that is increasingly nuanced. A clear example is the paper of Magness and coworkers1 in this issue of HEPATOLOGY, which explores the topic of stellate cell heterogeneity using an elegant genetic approach in mice to unearth subtle differences in cellular phenotype and plasticity. αSMA, alpha smooth muscle actin; TIMPs, tissue inhibitors of metalloproteinases; GFP, green fluorescent protein; RFP, red fluorescent protein. First, the "simple" view of stellate cell biology. Interest in these nonparenchymal persinusoidal cells, first described by Kupffer in the 19th century, was resurrected through the morphological studies of Ito, Popper, Wake and others.2 Stellate cells' unique capacity in liver to store vitamin A led to their identification in tissue and their isolation using density gradient methods.3, 4 These advances ushered in an exciting era of fibrosis research in which the phenotype of stellate cells was systematically characterized using culture and in vivo models, establishing them as capable of undergoing "activation" or transdifferentiation into a fibrogenic, proliferative, and contractile cell type that is at the core of the fibrotic response to liver injury.5 Because the initial isolation methods relied on a high content of vitamin A to enable their separation, a relatively homogeneous population of vitamin A–rich cells was isolated that, in retrospect, did not represent the full phenotypic spectrum of the cell type. Nonetheless, significant advances grew out of these approaches, in particular the characterization of intracellular filaments in stellate cells, cytoskeletal proteins whose composition was thought to represent the tissue of origin. Stellate cells were found to express desmin, a myogenic protein,6 as well as glial fibrillary protein, a marker of neural crest cells.7 Next, the expression of contractile filaments, alpha smooth muscle actin (αSMA), and then myosin were identified in stellate cells that had become activated in culture or in vivo.8, 9 These findings generated a straightforward paradigm in which vitamin A–rich stellate cells undergo activation in response to liver injury, losing their retinoid, and following a one-way path toward a fibrogenic and proliferative phenotype. The story became considerably more complicated as the heterogeneity of stellate cells and their related mesenchymal cell types became apparent.10 Rather than a single cell type with an identical retinoid and cytoskeletal phenotype, stellate cells appeared to contain variable amounts of vitamin A11 and differing combinations of intracellular filaments, depending on their lobular location, the species studied, and the nature of the liver injury (i.e., biliary vs. parenchymal). For example, an old concept of "portal fibroblasts" reemerged,12, 13 and it also became clear that there is a continuum of changes in gene expression during stellate cell activation, such that the quiescent cell first becomes activated, then continues to evolve into a myofibroblast-like cell.14 Moreover, activated stellate cells are distinct from myofibroblasts in their vitamin content, contractile activity, and relative responsiveness to cytokines, particularly transforming growth factor beta.15 A growing list of neural genes identified in stellate cells16 has broadened the potential combinations of markers that define subpopulations of this cell type. Even when stellate cells reach replicative senescence, the pattern of gene expression continues to evolve, with acquisition of a more inflammatory and less fibrogenic phenotype.17 Stellate cell plasticity was further appreciated with the recognition that their clearance from injured liver could be regulated by apoptosis, a pathway that is proving essential to allow recovery from liver injury and reversal of fibrosis.18 This response is also heterogeneous, with variable sensitivity to apoptosis, reflecting competing activities of apoptotic ligands and metalloproteases that may regulate cell death and their specific inhibitors, especially tissue inhibitors of metalloproteinases (TIMPs). A related source of conflicting data concerns the embryological origin of stellate cells, a question that has proven even more vexing as the overlapping myogenic, neural, and mesenchymal phenotypes are now fully recognized. The traditional view holds that stellate cells are derived from septum transversum as it invades gut endoderm, giving rise to a common stellate cell/sinusoidal endothelial cell precursor. However, this theory does not explain the extensive expression of neural crest markers, or the capacity for myogenic gene expression, including αSMA, myosin,19 and the transcription factors MyoD20 and MEF2.21 Finally, the anatomic and cellular source of activated stellate cells in liver has provoked controversy and intrigue. Although strong evidence suggests that the bulk of

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.20476

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

Metadata

Authors
Friedman, S. L.
Venue
Hepatology
Published
2004-11
Volume
40
Issue
5
Pages
1041-1043
ISSN
0270-9139 (ISSN-L)
OpenAlex
W2067845573
Cited by
121
References
4
FWCI
7.00
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.